
GC12222
Pexidartinib
Also listed as Pexidartinib (PLX3397)
Pexidartinib(PLX3397) is an orally administered small molecule tyrosine kinase inhibitor with potent selective activity against the colony-stimulating factor 1(CSF1) receptor(IC50=20nM), KIT proto-oncogene receptor tyrosine kinase(KIT)(IC50 =10nM) and FMS-like tyrosine kinase
ChemicalCAS1029044-16-3MW417.81FormulaC20H15ClF3N5
- CAS number
- 1029044-16-3
- Molecular weight
- 417.81
- Formula
- C20H15ClF3N5
- Solubility
- ≥ 20·9mg/mL in DMSO
- InChIKey
- JGWRKYUXBBNENE-UHFFFAOYSA-N
- Catalogue number
- GC12222
- Brand
- GLPBIO
Computed properties PubChem CID 25151352 · XLogP 4.5 · TPSA 66.5 Ų · H-bond donors 2
- XLogP
- 4.5
- TPSA
- 66.5 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 5
- Heavy atoms
- 29
SMILES C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F
Computed descriptors from PubChem (CID 25151352), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il